Colectomy |
0.038 (0.000–3.301;0.151) |
0.043 (0.000–3.816; 0.169) |
0.864 (0.489–1.527; 0.615) |
0.869 (0.486–1.553; 0.636) |
UC-related hospitalization |
0.385 (0.134–1.108; 0.077) |
0.379 (0.129–1.112; 0.077) |
0.751 (0.466–1.213; 0.242) |
0.774 (0.479–1.252; 0.297) |
Colon dysplasia |
NA |
NA |
3.119 (1.167–8.336; 0.023)
|
2.948 (1.158–7.504; 0.023)
|
Colorectal cancer |
NA |
NA |
2.785 (0.613–12.657; 0.185) |
2.480 (0.626–9.826; 0.196) |
Any complication (colectomy, UC-related hospitalization, colon dysplasia, and cancer) |
0.349 (0.120–1.009; 0.052) |
0.344 (0.117–1.012; 0.053) |
1.046 (0.727–1.503; 0.810) |
1.072 (0.744–1.543; 0.710) |
EIMs (any) |
1.441 (0.935–2.222; 0.098) |
1.455 (0.939–2.256; 0.094) |
1.494 (1.290–1.729; <0.001)
|
1.491 (1.289–1.724; <0.001)
|
Oral erosions/ulcerations |
1.213 (0.399–3.682; 0.733) |
1.254 (0.407–3.868; 0.694) |
1.216 (0.683–2.165; 0.506) |
1.212 (0.679–2.162; 0.516) |
Erythema nodosum |
0.261 (0.018–3.717;0.321) |
0.307 (0.027–3.508; 0.342) |
2.089 (0.846–5.156; 0.110) |
2.088 (0.847–5.146; 0.110) |
Pyoderma gangrenosum |
1.093 (0.127–9.442; 0.935) |
1.116 (0.145–8.558; 0.916) |
1.678 (0.204–13.782; 0.630) |
1.434 (0.138–14.917; 0.763) |
Arthritis/arthralgias |
2.048 (1.158–3.622; 0.014)
|
1.989 (1.131–3.498; 0.017)
|
1.426 (1.210–1.682; <0.001)
|
1.420 (1.204–1.674; <0.001)
|
Primary sclerosing cholangitis |
0.924 (0.378–2.257; 0.863) |
0.914 (0.320–2.613; 0.866) |
1.428 (0.860–2.370; 0.168) |
1.542 (0.931–2.555; 0.093) |
Uveitis/iritis |
3.134 (0.268–36.682; 0.363) |
3.563 (0.259–49.049; 0.342) |
1.392 (0.785–2.470; 0.258) |
1.392 (0.800–2.424; 0.242) |
Ankylosing spondylitis/sacroiliitis |
1.409 (0.180–11.051; 0.744) |
1.478 (0.175–12.511;0.720) |
3.404 (2.226–5.205; <0.001)
|
3.243 (2.154–4.882; <0.001)
|